🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This JAMA Guide to Statistics and Methods article explains effect score analyses, an approach for evaluating the heterogeneity of treatment effects, and examines its use in a study of oxygen-saturation targets in critically ill patients. #ISICEM24 ja.ma/48YCLNh

A blanket ban on the use of causal language in observational studies has long precluded nuanced discussion about which associations, if any, are truly causal   Fantastic work by Issa Dahabreh (CAUSALab BIDMC Smith Center) and Kirsten Bibbins-Domingo changes this jamanetwork.com/journals/jama/…

個人情報を含むので有料設定にしておりますが、私が約3ヶ月の勉強期間でOETに合格した経過をまとめました。もし興味があれば是非ご覧ください。OETに関する情報は少ないため、少しはお役に立てるかと思います。 OET合格体験記｜35歳からのUSMLE挑戦 @qwjrfYVw2F98273 #note note.com/famous_sedum37…

こちらの医療統計GPTですが最近のChatGPTのGoogleDriveとOnedriveとの連携によりさらに使いやすくなりました ✅統計手法が正しいか教科書は確認を ✅これを使えば統計ソフトは不要！ ✅論文のFigureにも利用可能 ✅グラフの日本語フォントにも対応 chatgpt.com/g/g-KLeiIzVny-…

📚 practical-stats-med-r.netlify.app 医療統計で R を使いたい人のための本 🧪 R の基礎（型・データ処理）からよく使う統計手法までを code を交えて解説 Base R 関数の code の他に，tidy に検定をパイプで追加できる rstatix 📦 (github.com/kassambara/rst…) を使用したものも例示しているのは特徴的

This is a study inspired from and dedicated to Sanjay Kaul, where we investigated the effect of using absolute rather than relative noninferiority margins in cardiovascular randomized trials. Recalculating noninferiority margins based on actual event rates, rather than expected

意外と知られてないけど、「Pythonによるデータ分析入門」第3版の原文は無料公開されている。 日本語化もされている人気書籍。 著者はPandasの開発者Wes Mckinney氏です。 データ分析で使うライブラリの知識はこれ1冊で足ります。 wesmckinney.com/book/

英語学習は継続が難しい。始めるのは簡単だけど、続けるのは大変。何かとお金がかかる問題も。 そんな悩みを解決する、無料の英語アプリのカオスマップはこちら。リスニング、ライティング、リーディング、スピーキング、英単語のそれぞれ強化できる！

CABG graft failure is more frequent in women than in men. Graft failure is associated with adverse cardiac events in women, but does not account for the excess mortality risk associated with female sex among CABG patients. bit.ly/3zwUCPy #cvCABG #MACE #JACC Dr. Deepak L. Bhatt

How does the presence of a CTO effect outcomes in FFR guided therapy for 3-vessel CAD? A comparison of PCI versus CABG. A FAME-3 Substudy Hisao Otsuki Tatsunori Takahashi, MD William Fearon #cardiotwitter #AHAJournals ahajrnls.org/3CEIInY

In the FAME 3 trial, at 3 years, women have similar outcomes with FFR-guided #PCI compared with #cvCABG, whereas men have improved outcomes with CABG. Read the journal scan to learn more: bit.ly/4glBUtY #JACCINT

How does a bifurcation lesion influence your revascularization strategy? Impact of bifurcation lesions on outcomes after FFR-guided PCI or CABG. Results from the FAME-3 Trial #cardiotwitter #CardioX #AHAJournals @bernardbruyne William Fearon Piroth Zsolt ahajrnls.org/4h6YZkD

The Target Trial Framework for Causal Inference From Observational Data: Why and When Is It Helpful? Miguel A. Hernán, Issa J. Dahabreh, Barbra A. Dickerman, et al. Annals of Internal Medicine. acpjournals.org/doi/10.7326/AN…

The benefit of coronary artery bypass grafting compared with fractional flow reserve-guided PCI with respect to MACCE at 3 years was similar among patients with and without diabetes. ja.ma/43FxtXW

Coronary Physiological Indices can be used to identify the functional significance of a myocardial bridge in patients with #INOCA Vedant Pargaonkar Hisao Otsuki Kuniaki Takahashi #cardiotwitter #AHAJournals ahajrnls.org/3YRavKr

LATE-Breaking trial @EuroPCR2025 Just published in EuroIntervention! The 4D-ACS trial demonstrates that 1-month DAPT followed by reduced-dose prasugrel monotherapy in ACS patients with drug-coated stents reduced net adverse clinical events by 49%, driven primarily by a reduction

あとで読む。AIベースの予測モデルにおけるサンプルサイズについて。 "Importance of sample size on the quality and utility of AI-based prediction models for healthcare" thelancet.com/journals/landi…

⌛ Episode 1 of Turning Point our new podcast is almost here! We kick off with none other than Patrick Serruys — a name that changed the course of interventional cardiology. Discover how it all began… 🎙️ Full episode coming very soon! #CardioEd #MedEd

Artificial intelligence (AI) has emerging applications in cardiovascular pharmacotherapy, including treatment selection, prediction of outcomes, and trial optimization. Our manuscript reviews current AI uses in therapy, trials, and drug discovery. academic.oup.com/eurheartj/adva…